Research progress of miRNA-206 on lung diseases

Abstract

CLC Number:

R563.5

ZHANG Lulu, WU Qiannan, HUO Rujie, et al. Research progress of miRNA-206 on lung diseases[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 413-417.

References45

[1]	van Schooneveld E, Wildiers H, Vergote I, et al. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management[J]. Breast Cancer Res, 2015, 17: 21. doi:10.1186/s13058-015-0526-ypmid:25849621
[2]	Pan Y, Liu L, Li S, et al. Activation of AMPK inhibits TGF-β1-induced airway smooth muscle cells proliferation and its potential mechanisms[J]. Sci Rep, 2018, 8(1): 3624. doi:10.1038/s41598-018-21812-0pmid:29483552
[3]	Berindan-Neagoe I, Monroig Pdel C, Pasculli B, et al. MicroRNAome genome: a treasure for cancer diagnosis and therapy[J]. CA Cancer J Clin, 2014, 64(5): 311-336. doi:10.3322/caac.21244 URL
[4]	Ma G, Wang Y, Li Y, et al. MiR-206, a key modulator of skeletal muscle development and disease[J]. Int J Biol Sci, 2015, 11(3): 345-352. doi:10.7150/ijbs.10921pmid:25678853
[5]	Holgate ST, Wenzel S, Postma DS, et al. Asthma[J]. Nat Rev Dis Primers, 2015, 1(1): 15025. doi:10.1038/nrdp.2015.25 URL
[6]	Peebles RS Jr, Aronica MA. Proinflammatory pathways in the pathogenesis of asthma[J]. Clin Chest Med, 2019, 40(1): 29-50. doi:S0272-5231(18)30125-4pmid:30691715
[7]	Park SJ, Lee YC. Interleukin-17 regulation: an attractive therapeutic approach for asthma[J]. Respir Res, 2010, 11(1): 78. doi:10.1186/1465-9921-11-78 URL
[8]	钱琴芬, 熊建新, 朱琳, 等. 发作期哮喘患儿外周血单个核细胞中miR-206表达变化及意义[J]. 山东医药, 2018, 58(37): 62-64.
[9]	Zheng H, Zhang X, Castillo EF, et al. Leptin enhances TH2 and ILC2 responses in allergic airway disease[J]. J Biol Chem, 2016, 291(42): 22043-22052. pmid:27566543
[10]	Kılıç A, Santolini M, Nakano T, et al. A systems immunology approach identifies the collective impact of 5 miRs in Th2 inflammation[J]. JCI Insight, 2018, 3(11): e97503. doi:10.1172/jci.insight.97503 URL
[11]	Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?[J]. Oxid Med Cell Longev, 2016, 2016: 5698931.
[12]	Wang L, Xu J, Liu H, et al. PM2.5 inhibits SOD1 expression by up-regulating microRNA-206 and promotes ROS accumulation and disease progression in asthmatic mice[J]. Int Immunopharmacol, 2019, 76: 105871. doi:10.1016/j.intimp.2019.105871 URL
[13]	Hough KP, Curtiss ML, Blain TJ, et al. Airway remodeling in asthma[J]. Front Med (Lausanne), 2020, 7: 191.
[14]	Ojiaku CA, Yoo EJ, Panettieri RA Jr. Transforming growth factor β1 function in airway remodeling and hyperresponsiveness. the missing link?[J]. Am J Respir Cell Mol Biol, 2017, 56(4): 432-442. doi:10.1165/rcmb.2016-0307TR URL
[15]	Kistemaker LEM, Prakash YS. Airway innervation and plasticity in asthma[J]. Physiology (Bethesda), 2019, 34(4): 283-298.
[16]	Goodwin K, Mao S, Guyomar T, et al. Smooth muscle differentiation shapes domain branches during mouse lung development[J]. Development, 2019, 146(22): dev181172.
[17]	Radzikinas K, Aven L, Jiang Z, et al. A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle[J]. J Neurosci, 2011, 31(43): 15407-15415. doi:10.1523/JNEUROSCI.2745-11.2011pmid:22031887
[18]	Clifford RL, Singer CA, John AE. Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function[J]. Pulm Pharmacol Ther, 2013, 26(1): 75-85. doi:10.1016/j.pupt.2012.07.002pmid:22800879
[19]	Rodrigo GJ. Advances in acute asthma[J]. Curr Opin Pulm Med, 2015, 21(1): 22-26. doi:10.1097/MCP.0000000000000123pmid:25405669
[20]	Kho AT, McGeachie MJ, Moore KG, et al. Circulating microRNAs and prediction of asthma exacerbation in childhood asthma[J]. Respir Res, 2018, 19(1): 128. doi:10.1186/s12931-018-0828-6 URL
[21]	Lei Y, Guo W, Chen B, et al. Tumor-released lncRNA H19 promotes gefitinib resistanceviapackaging into exosomes in non-small cell lung cancer[J]. Oncol Rep, 2018, 40(6): 3438-3446. doi:10.3892/or.2018.6762pmid:30542738
[22]	Jiang S, Liu X, Li D, et al. Study on attenuating angiogenesis and epithelial-mesenchymal transition(EMT) of non-small cell lung carcinoma(NSCLC) by regulating MAGEC2[J]. Technol Cancer Res Treat, 2018, 17: 15330 33818797587.
[23]	Zhang YX, Yan YF, Liu YM, et al. Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth[J]. Cell Death Dis, 2016, 7(12): e2528. doi:10.1038/cddis.2016.432 URL
[24]	Sun C, Liu Z, Li S, et al. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation[J]. Oncotarget, 2015, 6(28): 25533-25574. doi:10.18632/oncotarget.4575pmid:26325180
[25]	Chen QY, Jiao DM, Wu YQ, et al. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway[J]. Oncotarget, 2016, 7(14): 18247-18261. doi:10.18632/oncotarget.7570 URL
[26]	Zhang Y, Yao K, Shi C, et al. 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells[J]. Oncotarget, 2015, 6(42): 44274-44288. doi:10.18632/oncotarget.6236pmid:26517520
[27]	Jiao D, Chen J, Li Y, et al. miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT[J]. J Cell Mol Med, 2018, 22(7): 3526-3536. doi:10.1111/jcmm.13629pmid:29664235
[28]	Yang Y, Wang W, Chang H, et al. Reciprocal regulation of miR-206 and IL-6/STAT3 pathway mediates IL6-induced gefitinib resistance in EGFR-mutant lung cancer cells[J]. J Cell Mol Med, 2019, 23(11): 7331-7341. doi:10.1111/jcmm.14592pmid:31507089
[29]	Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report[J]. Am J Respir Crit Care Med, 2017, 195(5): 557-582. doi:10.1164/rccm.201701-0218PP URL
[30]	Jaitovich A, Barreiro E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2018, 198(2): 175-186. doi:10.1164/rccm.201710-2140CI URL
[31]	Donaldson A, Natanek SA, Lewis A, et al. Increased skeletal muscle-specific microRNA in the blood of patients with COPD[J]. Thorax, 2013, 68(12): 1140-1149. doi:10.1136/thoraxjnl-2012-203129pmid:23814167
[32]	Carpi S, Polini B, Nieri D, et al. Expression analysis of muscle-specific miRNAs in plasma-derived extracellular vesicles from patients with chronic obstructive pulmonary disease[J]. Diagnostics (Basel), 2020, 10(7): 502.
[33]	Chan SMH, Selemidis S, Bozinovski S, et al. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD)[J]. Pharmacol Ther, 2019, 198: 160-188. doi:10.1016/j.pharmthera.2019.02.013 URL
[34]	Morris HE, Neves KB, Montezano AC, et al. Notch3 signalling and vascular remodelling in pulmonary arterial hypertension[J]. Clin Sci (Lond), 2019, 133(24): 2481-2498. doi:10.1042/CS20190835pmid:31868216
[35]	Sun Y, An N, Li J, et al. miRNA-206 regulates human pulmonary microvascular endothelial cell apoptosis via targeting in chronic obstructive pulmonary disease[J]. J Cell Biochem, 2019, 120(4): 6223-6236. doi:10.1002/jcb.27910pmid:30335896
[36]	Mayeux JD, Pan IZ, Dechand J, et al. Management of pulmonary arterial hypertension[J]. Curr Cardiovasc Risk Rep, 2021, 15(1): 2. doi:10.1007/s12170-020-00663-3pmid:33224405
[37]	Lv Y, Fu L, Zhang Z, et al. Increased expression of microRNA-206 inhibits potassium voltage-gated channel subfamily a member 5 in pulmonary arterial smooth muscle cells and is related to exaggerated pulmonary artery hypertension following intrauterine growth retardation in rats[J]. J Am Heart Assoc, 2019, 8(2): e010456. doi:10.1161/JAHA.118.010456 URL
[38]	白延平, 李海军, 刘智娜. miR-206在大鼠肺动脉高压模型中的表达和意义[J]. 心脏杂志, 2019, 31(6): 654-659.
[39]	Yue J, Guan J, Wang X, et al. MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1α/Fhl-1 pathway[J]. Lab Invest, 2013, 93(7): 748-759. doi:10.1038/labinvest.2013.63pmid:23628900
[40]	Jalali S, Ramanathan GK, Parthasarathy PT, et al. miR-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation[J]. PLoS One, 2012, 7(10): e46808. doi:10.1371/journal.pone.0046808 URL
[41]	Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia[J]. Respir Med, 2017, 132: 170-177. doi:10.1016/j.rmed.2017.10.014 URL
[42]	Yen CY, Huang CY, Hou MF, et al. Evaluating the performance of fibronectin 1(FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC)[J]. Biomarkers, 2013, 18(1): 63-72. doi:10.3109/1354750X.2012.737025 URL
[43]	Duan J, Zhang X, Zhang S, et al. miR-206 inhibits FN1 expression and proliferation and promotes apoptosis of rat type Ⅱ alveolar epithelial cells[J]. Exp Ther Med, 2017, 13(6): 3203-3208. doi:10.3892/etm.2017.4430pmid:28587394
[44]	Zhang X, Xu J, Wang J, et al. Reduction of microRNA-206 contributes to the development of bronchopulmonary dysplasia through up-regulation of fibronectin 1[J]. PLoS One, 2013, 8(9): e74750. doi:10.1371/journal.pone.0074750 URL
[45]	Zhou J, Fu Y, Liu K, et al. miR-206 regulates alveolar type Ⅱ epithelial cell Cx43 expression in sepsis-induced acute lung injury[J]. Exp Ther Med, 2019, 18(1): 296-304.

Research progress of miRNA-206 on lung diseases

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References45

Related Articles13

Recommended Articles

Metrics

Comments

[1]	LI Zhen, PAN Lina, HU Jiaan, XU Zhihong.Clinical characteristics of 142 elderly patients with acute pulmonary embolism[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 379-384.
[2]	QIU Liwen, XU Yiming, ZHANG Yin, SHEN Honghua, CHEN Shen.Evaluate therapeutic efficacy of resistance training and aerobic training for gerontal patients with chronic obstructive pulmonary disease[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 78-83.
[3]	.[J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 97-101.
[4]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(04): 276-281.
[5]	XU Lei, XU Yiming, SHEN Honghua, ZHANG Yin, REN Lei.The impact of comorbidity of stroke and obstructive sleep-hypopnea apnea on sleep, cognition and nerve function[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 97-102.
[6]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 93-96.
[7]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 88-92.
[8]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 84-87.
[9]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 80-83.
[10]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 76-79.
[11]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 73-75.
[12]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 134-137.
[13]	.[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 60-63.